You can buy or sell TGTX and other stocks, options, ETFs, and crypto commission-free!
TG Therapeutics, Inc. Common Stock, also called TG Therapeutics, is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Read More Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Yahoo FinanceMar 11
What Makes TG Therapeutics (TGTX) a New Strong Buy Stock
TG Therapeutics (TGTX) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects.
Seeking AlphaMar 8
If You Want To Buy TG Therapeutics, Buy Now
I usually reserve earnings trades for Exposing Earnings, but this play is on too cheap of a stock to merit us playing (we would require too many option contracts to make the type of profit we typically seek).
-$0.42 per share
Expected Mar 29, Pre-Market